Skip to main content
Top
Published in: Inflammation 6/2016

01-12-2016 | ORIGINAL ARTICLE

Discovery of New Benzothiazine Derivative as Modulator of Pro- and Anti-inflammatory Cytokines in Rheumatoid Arthritis

Authors: Arham Shabbir, Muhammad Shahzad, Akbar Ali, Muhammad Zia-ur-Rehman

Published in: Inflammation | Issue 6/2016

Login to get access

Abstract

The anti-inflammatory activities of benzothiazine and pyrazole derivatives are well documented. A series of novel N′-arylmethylidene-2-(3,4-dimethyl-5,5-dioxidopyrazolo(4,3 c)(1,2) benzothiazin-2(4H)yl) acetohydrazide compounds were previously synthesized by combining benzothiazine and pyrazole moieties into a single nucleus. The current study investigates the anti-arthritic potential of 3-ethoxy-4-hydroxyphenyl derivative (EHP) and its possible mechanism in arthritic rat model. Sprague-Dawley rats were induced rheumatoid arthritis with Freund’s complete adjuvant and treated with EHP and piroxicam. At the end of the study, arthritic score was calculated, and ankle joint histopathology was performed using hematoxylin and eosin staining. Real-time reverse transcription polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) were used to determine mRNA expression and protein levels of various inflammatory markers, respectively. In vitro concanavalin A (ConA)-stimulated splenocyte proliferation was measured. Serum levels of C-reactive protein (CRP), urea, creatinine, aspartate aminotransferase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) were also determined. EHP significantly attenuated macroscopic arthritic score, joint histopathological lesions, and CRP levels. Treatment with EHP significantly reduced pro-inflammatory tissue necrosis factor-α (TNF-α), nuclear factor-kappa B (NF-кB), interleukin-17 (IL-17), and prostaglandin-E2 (PGE2) levels and increased the levels of anti-inflammatory interleukin-4 (IL-4) and interleukin-10 (IL-10). ConA-stimulated splenocyte proliferation was also significantly suppressed by treatment with EHP. Normalizing all hematological markers and ALP levels, EHP did not display any sign of nephrotoxicity and hepatotoxicity as determined by urea, creatinine, ALT, and AST levels. In conclusion, EHP possesses significant anti-arthritic property which may be attributed to its anti-inflammatory and immunomodulatory effects.
Literature
1.
go back to reference Brennan, F.M., and I.B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation 118: 3537–3545.CrossRefPubMedPubMedCentral Brennan, F.M., and I.B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation 118: 3537–3545.CrossRefPubMedPubMedCentral
2.
go back to reference McInnes, I.B., and G. Schett. 2011. The Pathogenesis of rheumatoid arthritis. The New England Journal of Medicine 365: 2205–2219.CrossRefPubMed McInnes, I.B., and G. Schett. 2011. The Pathogenesis of rheumatoid arthritis. The New England Journal of Medicine 365: 2205–2219.CrossRefPubMed
4.
go back to reference McInnes, I.B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 7(6): 429–442.CrossRefPubMed McInnes, I.B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 7(6): 429–442.CrossRefPubMed
5.
go back to reference Yang, M., H.B. Lin, S. Gong, P.Y. Chen, L.L. Geng, Y.M. Zeng, and D.Y. Li. 2014. Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis. Cytokine 70: 81–86.CrossRefPubMed Yang, M., H.B. Lin, S. Gong, P.Y. Chen, L.L. Geng, Y.M. Zeng, and D.Y. Li. 2014. Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis. Cytokine 70: 81–86.CrossRefPubMed
6.
go back to reference Brennan, F., and J. Beech. 2007. Update on cytokines in rheumatoid arthritis. Current Opinion in Rheumatology 19: 296–301.CrossRefPubMed Brennan, F., and J. Beech. 2007. Update on cytokines in rheumatoid arthritis. Current Opinion in Rheumatology 19: 296–301.CrossRefPubMed
7.
go back to reference Crofford, L.J. 2013. Use of NSAIDs in treating patients with arthritis. Arthritis Research and Therapy 15(Suppl.3): S2.PubMedPubMedCentral Crofford, L.J. 2013. Use of NSAIDs in treating patients with arthritis. Arthritis Research and Therapy 15(Suppl.3): S2.PubMedPubMedCentral
8.
go back to reference Grover, H.S., N. Gaba, A. Gupta, and C.M. Marya. 2011. Rheumatoid arthritis: a review and dental care considerations. Nepal Medical College Journal 13(2): 74–76.PubMed Grover, H.S., N. Gaba, A. Gupta, and C.M. Marya. 2011. Rheumatoid arthritis: a review and dental care considerations. Nepal Medical College Journal 13(2): 74–76.PubMed
9.
go back to reference Scott, D.L., F. Wolfe, and T.W. Huizinga. 2010. Rheumatoid arthritis. Lancet 376(9746): 1094–1108.CrossRefPubMed Scott, D.L., F. Wolfe, and T.W. Huizinga. 2010. Rheumatoid arthritis. Lancet 376(9746): 1094–1108.CrossRefPubMed
10.
go back to reference Mohy El-Din, M.M., A.M. Senbel, A.A. Bistawroos, A. El-Mallah, N.A. Nour El-Din, and A.A. Bekhit. 2011. Abd El Razik HA. A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. Basic and Clinical Pharmacology and Toxicology 108(4): 263–273.CrossRefPubMed Mohy El-Din, M.M., A.M. Senbel, A.A. Bistawroos, A. El-Mallah, N.A. Nour El-Din, and A.A. Bekhit. 2011. Abd El Razik HA. A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. Basic and Clinical Pharmacology and Toxicology 108(4): 263–273.CrossRefPubMed
11.
go back to reference Smith, S.R., G. Denhardt, and C. Terminelli. 2001. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models. European Journal of Pharmacology 432(1): 107–119.CrossRefPubMed Smith, S.R., G. Denhardt, and C. Terminelli. 2001. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models. European Journal of Pharmacology 432(1): 107–119.CrossRefPubMed
12.
go back to reference Zia-ur-Rehman, M., J.A. Choudary, S. Ahmad, and H.L. Siddiqui. 2006. Synthesis of potential biologically active 1,2-benzothiazin-3-yl-quinazolin-4(3H)-ones. Chemical and Pharmaceutical Bulletin 54: 1175–1178.CrossRefPubMed Zia-ur-Rehman, M., J.A. Choudary, S. Ahmad, and H.L. Siddiqui. 2006. Synthesis of potential biologically active 1,2-benzothiazin-3-yl-quinazolin-4(3H)-ones. Chemical and Pharmaceutical Bulletin 54: 1175–1178.CrossRefPubMed
13.
go back to reference Gennari, C., B. Salom, D. Potenza, and A. Williams. 1994. Synthesis of sulfonamido-pseudopeptides: new chiral unnatural oligomers. Angewandte Chemie (International Ed. in English) 33: 2067–2069.CrossRef Gennari, C., B. Salom, D. Potenza, and A. Williams. 1994. Synthesis of sulfonamido-pseudopeptides: new chiral unnatural oligomers. Angewandte Chemie (International Ed. in English) 33: 2067–2069.CrossRef
14.
go back to reference Shabbir, A., M. Shahzad, A. Ali, and M. Zia-ur-Rehman. 2014. Anti-arthritic activity of N′-[(2,4-dihydroxyphenyl)methylidene]-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl)acetohydrazide. European Journal of Pharmacology 738: 263–272.CrossRefPubMed Shabbir, A., M. Shahzad, A. Ali, and M. Zia-ur-Rehman. 2014. Anti-arthritic activity of N′-[(2,4-dihydroxyphenyl)methylidene]-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl)acetohydrazide. European Journal of Pharmacology 738: 263–272.CrossRefPubMed
15.
go back to reference Zia-ur-Rehman, M., J.A. Choudary, M.R.J. Elsegood, H.L. Siddiqui, and K.M. Khan. 2009. A facile synthesis of novel biologically active 4-hydroxy-N′-(benzylidene)-2H-benzo(e)(1,2)thiazine-3-carbohydrazide 1,1-dioxides. European Journal of Medicinal Chemistry 44: 1311–1316.CrossRefPubMed Zia-ur-Rehman, M., J.A. Choudary, M.R.J. Elsegood, H.L. Siddiqui, and K.M. Khan. 2009. A facile synthesis of novel biologically active 4-hydroxy-N′-(benzylidene)-2H-benzo(e)(1,2)thiazine-3-carbohydrazide 1,1-dioxides. European Journal of Medicinal Chemistry 44: 1311–1316.CrossRefPubMed
16.
go back to reference Ahmad, M., H.L. Siddiqui, M. Zia-ur-Rehman, and M. Parvez. 2010. Anti-oxidant and anti-bacterial activities of novel N′-arylmethylidene-2-(3,4-dimethyl-5,5-dioxidopyrazolo(4,3-c)(1,2)benzothiazin-2(4H)-yl)acetohydrazides. European Journal of Medicinal Chemistry 45: 698–704.CrossRefPubMed Ahmad, M., H.L. Siddiqui, M. Zia-ur-Rehman, and M. Parvez. 2010. Anti-oxidant and anti-bacterial activities of novel N′-arylmethylidene-2-(3,4-dimethyl-5,5-dioxidopyrazolo(4,3-c)(1,2)benzothiazin-2(4H)-yl)acetohydrazides. European Journal of Medicinal Chemistry 45: 698–704.CrossRefPubMed
17.
go back to reference Tong, B., Y. Dou, T. Wang, J. Yu, X. Wu, Q. Lu, G. Chou, Z. Wang, L. Kong, Y. Dai, and Y. Xia. 2015. Norisoboldine ameliorates collagen-induced arthritis through regulating the balance between Th17 and regulatory T cells in gut-associated lymphoid tissues. Toxicology and Applied Pharmacology 282: 90–99.CrossRefPubMed Tong, B., Y. Dou, T. Wang, J. Yu, X. Wu, Q. Lu, G. Chou, Z. Wang, L. Kong, Y. Dai, and Y. Xia. 2015. Norisoboldine ameliorates collagen-induced arthritis through regulating the balance between Th17 and regulatory T cells in gut-associated lymphoid tissues. Toxicology and Applied Pharmacology 282: 90–99.CrossRefPubMed
18.
go back to reference Jawed, H., S.U.A. Shah, S. Jamall, and S.U. Simjee. 2010. N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats. International Immunopharmacology 10: 900–905.CrossRefPubMed Jawed, H., S.U.A. Shah, S. Jamall, and S.U. Simjee. 2010. N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats. International Immunopharmacology 10: 900–905.CrossRefPubMed
19.
go back to reference Cai, X., H. Zhoua, Y.F. Wong, Y. Xie, Z.Q. Liu, Z.H. Jiang, Z.X. Bian, H.X. Xub, and L. Liu. 2007. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula. Journal of Ethnopharmacology 110: 39–48.CrossRefPubMed Cai, X., H. Zhoua, Y.F. Wong, Y. Xie, Z.Q. Liu, Z.H. Jiang, Z.X. Bian, H.X. Xub, and L. Liu. 2007. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula. Journal of Ethnopharmacology 110: 39–48.CrossRefPubMed
21.
go back to reference Patil KR, Patil CR, Jadhav RV, Mahajan VK, Patil PR, Gaikwad PS. Anti-Arthritic activity of Bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid-Based Comp Alter Med. 2011; Article ID 785245, 7 pages. doi:10.1093/ecam/nep148 Patil KR, Patil CR, Jadhav RV, Mahajan VK, Patil PR, Gaikwad PS. Anti-Arthritic activity of Bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid-Based Comp Alter Med. 2011; Article ID 785245, 7 pages. doi:10.​1093/​ecam/​nep148
22.
go back to reference Shinde, U.A., A.S. Phadake, A.M. Nair, A.A. Mungantiwar, V.J. Dishit, and M.N. Saraf. 1999. Studies on the anti-inflammatory and analgesic activity of Cedrus deodara (Roxb.) Loud. wood oil. Journal of Ethnopharmacology 65: 21–27.CrossRefPubMed Shinde, U.A., A.S. Phadake, A.M. Nair, A.A. Mungantiwar, V.J. Dishit, and M.N. Saraf. 1999. Studies on the anti-inflammatory and analgesic activity of Cedrus deodara (Roxb.) Loud. wood oil. Journal of Ethnopharmacology 65: 21–27.CrossRefPubMed
23.
go back to reference Tsai, C.C., and C.C. Lin. 1998. Anti-inflammatory effects of Taiwan folk medicine ‘Teng-Khia-U’ on carrageenan- and adjuvant-induced paw edema in rats. Journal of Ethnopharmacology 64(1): 85–89.CrossRef Tsai, C.C., and C.C. Lin. 1998. Anti-inflammatory effects of Taiwan folk medicine ‘Teng-Khia-U’ on carrageenan- and adjuvant-induced paw edema in rats. Journal of Ethnopharmacology 64(1): 85–89.CrossRef
24.
go back to reference Billiau, A., and P. Matthys. 2001. Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. Journal of Leukocyte Biology 70: 849–860.PubMed Billiau, A., and P. Matthys. 2001. Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases. Journal of Leukocyte Biology 70: 849–860.PubMed
25.
go back to reference Vasanthi, P., G. Nalini, and G. Rajashekhar. 2007. Role of tumor necrosis factor-alpha in rheumatoid arthritis: a review. APLAR Journal of Rheumatology 10: 270–274.CrossRef Vasanthi, P., G. Nalini, and G. Rajashekhar. 2007. Role of tumor necrosis factor-alpha in rheumatoid arthritis: a review. APLAR Journal of Rheumatology 10: 270–274.CrossRef
26.
go back to reference Butler, D.M., R.N. Maini, M. Feldmann, and F.M. Brennan. 1995. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of monoclonal anti TNF-α antibody with interleukin-1 receptor antagonist. European Cytokine Network 6: 225–230.PubMed Butler, D.M., R.N. Maini, M. Feldmann, and F.M. Brennan. 1995. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of monoclonal anti TNF-α antibody with interleukin-1 receptor antagonist. European Cytokine Network 6: 225–230.PubMed
27.
go back to reference Haworth, C., F.M. Brennan, D. Chantry, M. Turner, R.N. Maini, and M. Feldmann. 1991. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. European Journal of Immunology 21: 2575–2579.CrossRefPubMed Haworth, C., F.M. Brennan, D. Chantry, M. Turner, R.N. Maini, and M. Feldmann. 1991. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. European Journal of Immunology 21: 2575–2579.CrossRefPubMed
28.
go back to reference Chin, J.E., G.E. Winterrowd, R.F. Krzesicki, and M.E. Sanders. 1990. Role of cytokines in inflammatory synovitis: the coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis and Rheumatism 33: 1776–1786.CrossRefPubMed Chin, J.E., G.E. Winterrowd, R.F. Krzesicki, and M.E. Sanders. 1990. Role of cytokines in inflammatory synovitis: the coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis and Rheumatism 33: 1776–1786.CrossRefPubMed
29.
go back to reference Makrov, S.S. 2001. NF-kB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Research 3: 200–206.CrossRef Makrov, S.S. 2001. NF-kB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Research 3: 200–206.CrossRef
30.
go back to reference Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18: 6853–6866.CrossRefPubMed Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18: 6853–6866.CrossRefPubMed
31.
go back to reference Khan, A.M., M. Shahzad, M.B. Raza Asim, and A. Shabbir. 2015. Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response. Pharmaceutical Biology 53(3): 359–367.CrossRefPubMed Khan, A.M., M. Shahzad, M.B. Raza Asim, and A. Shabbir. 2015. Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response. Pharmaceutical Biology 53(3): 359–367.CrossRefPubMed
32.
go back to reference Ohmura, K., L.T. Nguyen, R.M. Locksley, D. Mathis, and C. Benoist. 2005. Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis and Rheumatism 52(6): 1866–1875.CrossRefPubMed Ohmura, K., L.T. Nguyen, R.M. Locksley, D. Mathis, and C. Benoist. 2005. Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis and Rheumatism 52(6): 1866–1875.CrossRefPubMed
33.
go back to reference Schulze-Koops, H., and J.R. Kalden. 2001. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 15(5): 677–691.CrossRef Schulze-Koops, H., and J.R. Kalden. 2001. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 15(5): 677–691.CrossRef
34.
go back to reference Clair, E.W. 1999. Interleukin 10 treatment for rheumatoid arthritis. Ann. Rheumatic Disease 58: I99–I102.CrossRef Clair, E.W. 1999. Interleukin 10 treatment for rheumatoid arthritis. Ann. Rheumatic Disease 58: I99–I102.CrossRef
35.
go back to reference Asadullah, K., W. Sterry, and H.D. Volk. 2003. Interleukin-10 therapy-review of a new approach. Pharmacological Reviews 55: 241–269.CrossRefPubMed Asadullah, K., W. Sterry, and H.D. Volk. 2003. Interleukin-10 therapy-review of a new approach. Pharmacological Reviews 55: 241–269.CrossRefPubMed
36.
go back to reference van Roon, J.A., J.L. van Roy, F.H. Gmelig-Meyling, F.P. Lafeber, and J.W. Bijlsma. 1996. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis and Rheumatism 39(5): 829–835.CrossRefPubMed van Roon, J.A., J.L. van Roy, F.H. Gmelig-Meyling, F.P. Lafeber, and J.W. Bijlsma. 1996. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis and Rheumatism 39(5): 829–835.CrossRefPubMed
38.
go back to reference Jovanovic, D.V., J.A. Di Battista, J. Martel-Pelletier, F.C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J.P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-b and TNF-a, by human macrophages. The Journal of Immunology 60: 3513–3521. Jovanovic, D.V., J.A. Di Battista, J. Martel-Pelletier, F.C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J.P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-b and TNF-a, by human macrophages. The Journal of Immunology 60: 3513–3521.
39.
go back to reference Jovanovic, D.V., J.A. Di Battista, Martel-Pelletier, J. Martel-Pelletier, P. Reboul, Y. He, F.C. Jolicoeur, and J.P. Pelletier. 2001. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages. Journal of Rheumatology 28: 712–718.PubMed Jovanovic, D.V., J.A. Di Battista, Martel-Pelletier, J. Martel-Pelletier, P. Reboul, Y. He, F.C. Jolicoeur, and J.P. Pelletier. 2001. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages. Journal of Rheumatology 28: 712–718.PubMed
40.
go back to reference Jovanovic, D.V., J. Martel-Pelletier, J.A. Di Battista, F. Mineau, F.C. Jolicoeur, M. Benderdour, and J.P. Pelletier. 2000. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis and Rheumatism 43: 1134–1144.CrossRefPubMed Jovanovic, D.V., J. Martel-Pelletier, J.A. Di Battista, F. Mineau, F.C. Jolicoeur, M. Benderdour, and J.P. Pelletier. 2000. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis and Rheumatism 43: 1134–1144.CrossRefPubMed
41.
go back to reference Shahrara, S., S.R. Pickens, A. Dorfleutner, and R.M. Pope. 2009. IL-17 induces monocyte migration in rheumatoid arthritis. The Journal of Immunology 182: 3884–3891.CrossRefPubMedPubMedCentral Shahrara, S., S.R. Pickens, A. Dorfleutner, and R.M. Pope. 2009. IL-17 induces monocyte migration in rheumatoid arthritis. The Journal of Immunology 182: 3884–3891.CrossRefPubMedPubMedCentral
43.
go back to reference Dannhardt, G., and W. Kiefer. 2001. Cyclooxygenase inhibitors – current status and future prospects. European Journal of Medicinal Chemistry 36: 109–126.CrossRefPubMed Dannhardt, G., and W. Kiefer. 2001. Cyclooxygenase inhibitors – current status and future prospects. European Journal of Medicinal Chemistry 36: 109–126.CrossRefPubMed
44.
go back to reference Hirai, H., K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. The Journal of Experimental Medicine 193(2): 255–261.CrossRefPubMedPubMedCentral Hirai, H., K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. The Journal of Experimental Medicine 193(2): 255–261.CrossRefPubMedPubMedCentral
45.
go back to reference Crofford, L.J., R.L. Wilder, and A.P. Ristimaki. 1994. Cyclooxygenase-1 and −2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. The Journal of Clinical Investigation 93(3): 1095–1101.CrossRefPubMedPubMedCentral Crofford, L.J., R.L. Wilder, and A.P. Ristimaki. 1994. Cyclooxygenase-1 and −2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. The Journal of Clinical Investigation 93(3): 1095–1101.CrossRefPubMedPubMedCentral
46.
go back to reference Ma J, Song B, Ruan H, Zhoou P, Cui P. Effect of berberine hydrochloride on the proliferation, apoptosis and cytokine secretion of splenocytes in mice. Xi. Bao. Yu Fen Zi Mian Yi Xue Za Zhi. 2013;29(8):802–804. (article in Chinese). Ma J, Song B, Ruan H, Zhoou P, Cui P. Effect of berberine hydrochloride on the proliferation, apoptosis and cytokine secretion of splenocytes in mice. Xi. Bao. Yu Fen Zi Mian Yi Xue Za Zhi. 2013;29(8):802–804. (article in Chinese).
47.
go back to reference Ekambaram, S., S.S. Perumal, and V. Subramanian. 2010. Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund’s adjuvant induced arthritic rat model. BMC Comp Alt Med. 10: 56. doi:10.1186/1472-6882-10-56.CrossRef Ekambaram, S., S.S. Perumal, and V. Subramanian. 2010. Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund’s adjuvant induced arthritic rat model. BMC Comp Alt Med. 10: 56. doi:10.​1186/​1472-6882-10-56.CrossRef
48.
go back to reference Mishra, N.K., S. Bstia, G. Mishra, K.A. Chowdary, and S. Patra. 2011. Anti-arthritic activity of Glycyrrhiza glabra, Boswellia serrata and their synergistic activity in combined formulation studied in freund’s adjuvant induced arthritic rats. Journal of Pharmaceutical and Educational Research 2(2): 92–98. Mishra, N.K., S. Bstia, G. Mishra, K.A. Chowdary, and S. Patra. 2011. Anti-arthritic activity of Glycyrrhiza glabra, Boswellia serrata and their synergistic activity in combined formulation studied in freund’s adjuvant induced arthritic rats. Journal of Pharmaceutical and Educational Research 2(2): 92–98.
49.
go back to reference Coelho, M.G.P., P.A. Reisa, V.B. Gavaa, P.R. Marquesa, C.R. Gayera, G.A.T. Laranjaa, I. Felzenswalbb, and K.C.C. Sabinoa. 2004. Anti-arthritic effect and subacute toxicological evaluation of Baccharis genistelloides aqueous extract. Toxicology Letters 154: 69–80.CrossRefPubMed Coelho, M.G.P., P.A. Reisa, V.B. Gavaa, P.R. Marquesa, C.R. Gayera, G.A.T. Laranjaa, I. Felzenswalbb, and K.C.C. Sabinoa. 2004. Anti-arthritic effect and subacute toxicological evaluation of Baccharis genistelloides aqueous extract. Toxicology Letters 154: 69–80.CrossRefPubMed
Metadata
Title
Discovery of New Benzothiazine Derivative as Modulator of Pro- and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Authors
Arham Shabbir
Muhammad Shahzad
Akbar Ali
Muhammad Zia-ur-Rehman
Publication date
01-12-2016
Publisher
Springer US
Published in
Inflammation / Issue 6/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0427-y

Other articles of this Issue 6/2016

Inflammation 6/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.